MANTA Percutaneous Vascular Closure Device - The SAFE MANTA Study

NACompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

December 31, 2017

Conditions
Femoral Arteriotomy Closure
Interventions
DEVICE

MANTA vascular closure device

The appropriate size of MANTA closure device will be selected and used for the closure of femoral arterial access sites following the use of 10-14F devices or sheaths or the use of 15-18F devices or sheaths.

Trial Locations (19)

10032

Columbia University Medical Center, New York

17033

Hershey Medical Center, Hershey

19096

Lankenau Heart Group, Wynnewood

19140

Temple University Hospital, Philadelphia

20010

Washington Hospital Center, Washington D.C.

25304

CAMC Memorial Hospital, Charleston

37660

Wellmont Holston Valley Hospital, Kingsport

44195

Cleveland Clinic, Cleveland

46290

St. Vincent Heart Center, Indianapolis

48202

Henry Ford, Detroit

57108

Avera Heart Hospital, Sioux Falls

60201

Evanston Hospital, Evanston

64111

St. Luke Hospital (Mid America Heart), Kansas City

75093

The Heart Hospital Baylor Plano, Plano

77030

Houston Methodist, Houston

St. Luke's Hospital - Texas Heart, Houston

92161

San Diego VA Medical Center, San Diego

98122

Swedish Medical Center, Seattle

Unknown

St. Paul's Hospital, Vancouver

Sponsors
All Listed Sponsors
lead

Essential Medical, Inc.

INDUSTRY

NCT02908880 - MANTA Percutaneous Vascular Closure Device - The SAFE MANTA Study | Biotech Hunter | Biotech Hunter